Tratamiento de la enfermedad hemorroidal mediante desarterialización y hemorroidopexia. Experiencia de varias unidades especializadas☆

Noguerales, F; Dı́az, Raúl; Salim, Basar; Piniella, Fernando; Landaluce, Aitor; Garcea, Alessandro; Pérez, Juan de Mata López

doi:10.1016/j.ciresp.2014.04.012

Cited by 7 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several prospective series [5][6][7][8][9][10][11][12][13][14][15] reported good results in the treatment of HD grades III-IV with HAL-RAR, with low recurrence rates (9% to 27%), but a relatively short follow-up period (12-36 months). In our experience, HAL-RAR achieves control of HD symptoms in patients with grades III-IV hemorrhoids with a recurrence rate of 3.3% after 2 years of follow-up.…”

Section: Discussionmentioning

confidence: 99%

“…3 HAL results have been improved when associated with fixation of prolapsed tissue with mucopexy or recto-anal repair (RAR). [4][5][6][7][8][9][10][11][12][13][14][15] As previously stated, the primary aim of this study is to compare the postoperative pain of HAL-RAR with EH, and the secondary outcomes are the following: symptom resolution rates, postoperative morbidity, early recurrence, and changes in quality of life.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prospective Randomized Trial Comparing HAL-RAR Versus Excisional Hemorrhoidectomy: Postoperative Pain, Clinical Outcomes, and Quality of Life

et al. 2019

View full text Add to dashboard Cite

Purpose. To compare outcomes of hemorrhoid artery ligation with recto-anal repair (HAL-RAR) and excisional hemorrhoidectomy (EH). The primary objective was to compare postoperative pain, and the secondary objectives were the following: symptom resolution rates, postoperative morbidity, recurrence, and changes in quality of life. Method. Prospective randomized controlled trial, including 40 patients with grades III-IV hemorrhoids who were allocated 1:1 to HAL-RAR and EH. Follow-up evaluation was performed at 15 days, 30 days, 6 months, 12 months, and then annually. Pain was measured using a Visual Analogic Scale and was self-recorded by patients. Quality of life was measured with Short Form Survey-36 questionnaire. Results. Postoperative pain was lower in the HAL-RAR group during the first 30 postoperative days. Moreover, from day 7 onward more patients in the HAL-RAR group reported complete absence of pain (Visual Analogic Scale score = 0). Globally, symptom resolution was significantly higher (P = .03) in the HAL-RAR group at day 15. Bleeding resolution was observed earlier in the HAL-RAR group than in the EH group (P = .04), but no differences in the resolution of prolapse, itching, and soiling were observed during the 30-day follow-up. After a mean follow-up of 15 months (range 12-27 months), no differences in postoperative morbidity and no recurrences were observed. An improvement was observed in all sections evaluated by the Short Form Survey-36 questionnaire with both techniques. Conclusion. HAL-RAR provokes less postoperative pain during a shorter period than EH and achieves resolution of hemorrhoidal symptoms with less postoperative complaints. No differences in morbidity and recurrence rate were observed after 12 months of follow-up.

show abstract